ChemicalBook > CAS DataBase List > Lecanemab

Lecanemab

Product Name
Lecanemab
CAS No.
1260393-98-3
Chemical Name
Lecanemab
Synonyms
BAN-2401;Lecanemab;Lecanemab (anti-Amyloid Beta);Research Grade Lecanemab (DHC12506)
CBNumber
CB910616957
Formula Weight
0
MOL File
Mol file
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Lecanemab Chemical Properties,Usage,Production

Description

Lecanemab is an amyloid beta-targeting antibody used to treat Alzheimer’s Disease in patients with mild cognitive impairment or mild dementia with a known amyloid beta pathology. It is for use in people who have only one or no copy of ApoE4, a certain form of the gene for the protein apolipoprotein E, and who have amyloid beta plaques in the brain.

History

In July 2022, the US Food and Drug Administration (FDA) accepted an application for accelerated approval for lecanemab.
In September 2022, Biogen announced positive results from an ongoing phase III clinical trial.
In November 2022, it was announced that the drug was a success in clinical trials, and exceeded its goal in reaching primary endpoints.
On January 6, 2023, lecanemab was granted accelerated approval by the FDA for the treatment of Alzheimer’s Disease. It was granted full FDA approval on July 6, 2023.

Side effects

Safety and efficacy of lecanemab are known only for patients like those participating in the phase 2 and phase 3 lecanemab trials, and these AURs adhere closely to the inclusion and exclusion criteria of the trials. Adverse events may occur with lecanemab including amyloid related imaging abnormalities (ARIA) and infusion reactions. Most ARIA with lecanemab is asymptomatic, but a few cases are serious or, very rarely, fatal.

Lecanemab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Lecanemab Suppliers

Wuhan Sunrise Technology Development Co., Ltd.
Tel
27-027-83314682 13554138826
Fax
+86 (27) 8331-4682
Email
whsrtech@vip.163.com
Country
China
ProdList
246
Advantage
62
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com
Country
China
ProdList
3239
Advantage
55
Shanghai URChem Limited
Tel
+86-021-50890968,021-50891159 +86-18601776121
Fax
086-21-68416099 58604179
Email
danny@urchem.com
Country
China
ProdList
628
Advantage
58
Shanghai Macklin Biochemical Co.,Ltd.
Tel
15221275939
Fax
021-50706099
Email
shenlinxing@macklin.cn
Country
China
ProdList
15873
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Hefei Hirisun Pharmatech Co., Ltd.
Tel
+86-0551-62678551 +86-15056975894
Fax
05512678551
Email
sales@hirisunpharm.com
Country
China
ProdList
176
Advantage
55
Shanghai Zhibang Biological Medicine Co., LTD
Tel
021-54285032 18116461626
Fax
021-54285032
Email
25493162@qq.com
Country
China
ProdList
148
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58

1260393-98-3, LecanemabRelated Search:


  • Lecanemab
  • Research Grade Lecanemab (DHC12506)
  • BAN-2401
  • Lecanemab (anti-Amyloid Beta)
  • 1260393-98-3